YO‘LDOSHDA QON AYLANISHI PATOLOGIYASINING GEMATOLOGIK VA PATOMORFOLOGIK JIHATLARI VA ULARNING PERINATAL ASORATLARNI OLDINI OLISHDAGI AHAMIYATI
DOI:
https://doi.org/10.5281/zenodo.23533663Keywords:
platsenta, gemostaz, malperfuziya, tromboz, preeklampsiya, homila o‘sishining cheklanishi, perinatal xavfAbstract
Maqolada platsentar qon aylanishi buzilishlari, gematologik holat, ona va homila tomirlarining malperfuziyasi hamda perinatal asoratlar o‘rtasidagi bog‘liqlik ilmiy manbalar asosida tahlil qilindi. Amsterdam tasnifiga asoslangan morfologik belgilar, Doppler va klinik-laborator tekshiruvlarning o‘zaro to‘ldiruvchanligi o‘rganildi. Maqola adabiyotlar tahlili bo‘lib, original bemor ma’lumotlarini o‘z ichiga olmaydi.References
1. O‘zbekiston Respublikasi Prezidenti. (2023). Onalar va bolalar salomatligini muhofaza qilish, aholining reproduktiv salomatligini mustahkamlash chora-tadbirlari to‘g‘risida (PQ-296). https://www.lex.uz/acts/-6598641
2. O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. (2025). Klinik protokollar va standartlar. https://gov.uz/ oz/ssv/pages/klinik-qo-llanmalar
3. O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. (2024). Milliy/mahalliy klinik protokollarni ishlab chiqish metodologiyasi. https://gov.uz/oz/ssv/pages/metodologiya
4. O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. (2025). Milliy klinik protokol va standartlarni xalqaro mezonlarga moslashtirish davom etmoqda. https://gov.uz/oz/ssv/news/view/54183
5. Khong, T. Y., Mooney, E. E., Ariel, I., et al. (2016). Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group consensus statement. Archives of Pathology & Laboratory Medicine, 140(7), 698–713. https://doi.org/10.5858/arpa.2015-0225-CC
6. Parra-Herran, C. (2022). Life after Amsterdam: Placental pathology consensus recommendations and beyond. https://pubmed.ncbi.nlm.nih.gov/35715157/
7. Cersonsky, T. E. K., Silver, R. M., Saade, G. R., et al. (2023). Macroscopic lesions of maternal and fetal vascular malperfusion in stillborn placentas. Placenta, 140, 60–65. https://doi.org/10.1016/j. placenta.2023.07.296
8. Fetal growth restriction and stillbirth: Biomarkers for identifying at risk fetuses. (2022). https://pmc.ncbi. nlm.nih.gov/articles/PMC9437293/
9. Spinillo, A., Dominoni, M., Dal Mas, F., et al. (2023). Placental fetal vascular malperfusion, neonatal neurologic morbidity, and infant neurodevelopmental outcomes. American Journal of Obstetrics and Gynecology, 229(6), 632–640.e2. https://doi.org/10.1016/j.ajog.2023.06.014
10. Freedman, A. A., Price, E., Franklin, A., & Ernst, L. M. (2023). Measures of fetal growth and cardiac structure in stillbirths with placental maternal vascular malperfusion. Pediatric and Developmental Pathology, 26(3), 310–317. https://doi.org/10.1177/10935266231166548
11. Shmueli, A., Mor, L., Blickstein, O., et al. (2023). Placental pathology in pregnancies with late fetal growth restriction and abnormal cerebroplacental ratio. Placenta, 138, 83–87. https://doi.org/10.1016/j. placenta.2023.05.010
12. Society for Maternal-Fetal Medicine. (2020). Consult Series #52: Diagnosis and management of fetal growth restriction. https://www.smfm.org/publications/289-smfm-consult-series-52-diagnosis-and-managementof-fetal-growth-restriction
Downloads
Published
How to Cite
Issue
Section
